Trial Profile
Clinical Trials Insight: 700028789
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2007
Price :
$35
*
At a glance
- Drugs Teverelix (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Ardana plc
- 26 Nov 2007 New trial record.
- 22 Nov 2007 Preliminary results have been reported by Ardana Bioscience.